Pro-Dex (co) (PDEX) has a profit margin of 17.62%, above the Healthcare sector average of 10.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Pro-Dex (co) posts a profit margin of 17.62% as of June 2026. That compares with 13.48% in the prior-year period — up 30.7% year over year. That is above the Healthcare sector average of 10.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Pro-Dex (co)'s profit margin was 13.48%. The latest reading is 17.62% — a 30.7% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a profit margin near 10.58% is typical. Pro-Dex (co)'s 17.62% is higher that level. That is roughly 66.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Pro-Dex (co)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 17.62% as of June 2026; use YoY and peer views to separate noise from signal.
Context for PDEX's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.58%), and (3) consistency with growth and profitability. This page covers the first two; Pro-Dex (co)'s other metric pages and overview cover the third.